The treatment of cardiogenic shock in patients with Takotsubo syndrome (TTS) is challenging because it depends on the mechanisms leading to the haemodynamic instability. We report the case of a 70-year-old woman admitted for TTS complicated by cardiogenic shock. The early echocardiographic identification of left ventricular outflow tract obstruction (LVOTO) and severe mitral regurgitation (MR) prompted us to implant an Impella CP assist device as a bridge-to-recovery therapy. After device positioning, the haemodynamic status improved and LVOTO and severe MR disappeared. Because of the persistence of severe hypotension, the mechanical circulatory support was continued in intensive care unit and stopped only 5 days later, when intraventricula...
Chemotherapy induced cardiotoxicity is becoming increasingly prevalent with several new agents being...
INTRODUCTION: Takotsubo cardiomyopathy (TCM) can be complicated by left ventricular outflow tract (L...
Impella LP 5.0 is a microaxial left ventricular assist device (LVAD). The aim of our work was to ass...
The treatment of cardiogenic shock in patients with Takotsubo syndrome (TTS) is challenging because ...
Severe sepsis has been known to trigger for takotsubo syndrome which is associated with profound phy...
Background: Takotsubo Cardiomyopathy (TC) in severecases may present with profound LV outfow tract (...
In patients with left ventricular output failure, the Impella left ventricular assist device increas...
Takotsubo syndrome (TTS) is characterized by acute, generally transient left ventricular (LV) dysfun...
We report a case of a 73-year-old female patient, who was admitted to the coronary care unit due to ...
Background: Takotsubo cardiomyopathy is a variant of acute coronary syndrome with characteristic acu...
Background: Cardiogenic shock occurs in 10%-15% of patients with Takotsubo syndrome (TS). For severa...
Background: Cardiogenic shock occurs in 10%-15% of patients with Takotsubo syndrome (TS). For severa...
SummaryAimCardiogenic shock is associated with high mortality. We report our experience with the sho...
Introduction: Takotsubo cardiomyopathy (TCM) can be complicated by left ventricular outflow tract (L...
Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most co...
Chemotherapy induced cardiotoxicity is becoming increasingly prevalent with several new agents being...
INTRODUCTION: Takotsubo cardiomyopathy (TCM) can be complicated by left ventricular outflow tract (L...
Impella LP 5.0 is a microaxial left ventricular assist device (LVAD). The aim of our work was to ass...
The treatment of cardiogenic shock in patients with Takotsubo syndrome (TTS) is challenging because ...
Severe sepsis has been known to trigger for takotsubo syndrome which is associated with profound phy...
Background: Takotsubo Cardiomyopathy (TC) in severecases may present with profound LV outfow tract (...
In patients with left ventricular output failure, the Impella left ventricular assist device increas...
Takotsubo syndrome (TTS) is characterized by acute, generally transient left ventricular (LV) dysfun...
We report a case of a 73-year-old female patient, who was admitted to the coronary care unit due to ...
Background: Takotsubo cardiomyopathy is a variant of acute coronary syndrome with characteristic acu...
Background: Cardiogenic shock occurs in 10%-15% of patients with Takotsubo syndrome (TS). For severa...
Background: Cardiogenic shock occurs in 10%-15% of patients with Takotsubo syndrome (TS). For severa...
SummaryAimCardiogenic shock is associated with high mortality. We report our experience with the sho...
Introduction: Takotsubo cardiomyopathy (TCM) can be complicated by left ventricular outflow tract (L...
Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most co...
Chemotherapy induced cardiotoxicity is becoming increasingly prevalent with several new agents being...
INTRODUCTION: Takotsubo cardiomyopathy (TCM) can be complicated by left ventricular outflow tract (L...
Impella LP 5.0 is a microaxial left ventricular assist device (LVAD). The aim of our work was to ass...